понедельник, 11 января 2016 г.

Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management

Alexion Pharmaceuticals, Inc. (ALXN) Position Decreased by EQIS Capital Management


EQIS Capital Management decreased its stake in Alexion Pharmaceuticals, Inc. by 51.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 9,974 shares of the biopharmaceutical company's stock after selling 10,740 shares during the period.



from Biotech News